The incidence of new vertebral compression fractures in women after kyphoplasty and factors involved
- PMID: 17722237
- PMCID: PMC2628047
- DOI: 10.3349/ymj.2007.48.4.645
The incidence of new vertebral compression fractures in women after kyphoplasty and factors involved
Abstract
Purpose: To identify the incidence of new vertebral compression fractures in women after kyphoplasty and to analyze influential factors in these patients.
Materials and methods: One hundred and eleven consecutive female patients with osteoporotic vertebral compression fractures (VCFs) underwent kyphoplasty at 137 levels. These patients were followed for 15.2 months postoperatively. For the survey of new vertebral compression fractures, medical records and x-rays were reviewed, and telephone interviews were conducted with all patients.
Results: During that time 20 (18%) patients developed new VCFs. The rate of occurrence of new VCFs in one year was 15.5% using a Kaplan-Meier curve. Body mass index (BMI), symptom duration and kyphoplasty level were the statistically significant factors between the patient groups both with and without new VCFs after kyphoplasty. In the comparison between the adjacent and remote new VCF groups, the adjacent new VCF group showed a larger amount of polymethyl methacrylate (PMMA) use during kyphoplasty (p<0.05). Before kyphoplasty, 9.9% of the patients had been prescribed medication for osteoporosis, and 93.7% of the patients started or continued medication after kyphoplasty. The development of new VCFs was affected by the number of vertebrae involved in the kyphoplasty. However, the lower incidence rate (15.5%) of new compression fractures might be due to a greater percentage (93.7% in our study) of patients taking anti-osteoporotic medication before and/or after kyphoplasty.
Conclusion: When kyphoplasty is planned for the management of patients with osteoporotic VCFs, the application of a small amount of PMMA can be considered in order to lower the risk of new fractures in adjacent vertebrae. The postoperative use of anti- osteoporotic medication is recommended for the prevention of new VCFs.
Figures
Similar articles
-
Preliminary outcomes and efficacy of the first 360 consecutive kyphoplasties for the treatment of painful osteoporotic vertebral compression fractures.Spine J. 2005 May-Jun;5(3):244-55. doi: 10.1016/j.spinee.2004.09.013. Spine J. 2005. PMID: 15863078
-
A Longitudinal Cohort Investigation of the Development of Symptomatic Adjacent Level Compression Fractures Following Balloon-assisted Kyphoplasty in a Series of 726 Patients.Pain Physician. 2016 Nov-Dec;19(8):E1167-E1172. Pain Physician. 2016. PMID: 27906947
-
Balloon kyphoplasty for vertebral compression fractures in solid organ transplant recipients: results of treatment and comparison with primary osteoporotic vertebral compression fractures.Spine J. 2006 Sep-Oct;6(5):494-9. doi: 10.1016/j.spinee.2006.01.011. Epub 2006 Jul 24. Spine J. 2006. PMID: 16934717 Clinical Trial.
-
Incidence of subsequent vertebral fracture after kyphoplasty.Spine (Phila Pa 1976). 2004 Oct 15;29(20):2270-6; discussion 2277. doi: 10.1097/01.brs.0000142469.41565.2a. Spine (Phila Pa 1976). 2004. PMID: 15480139 Review.
-
The present role of vertebroplasty and kyphoplasty in the treatment of fresh vertebral compression fractures.Minerva Chir. 2010 Aug;65(4):429-37. Minerva Chir. 2010. PMID: 20802431 Review.
Cited by
-
Does the Time of Postoperative Bisphosphonate Administration Affect the Bone Union in Osteoporotic Intertrochanteric Fracture of Femur?Hip Pelvis. 2015 Dec;27(4):258-64. doi: 10.5371/hp.2015.27.4.258. Epub 2015 Dec 30. Hip Pelvis. 2015. PMID: 27536634 Free PMC article.
-
Risk factors predicting the new symptomatic vertebral compression fractures after percutaneous vertebroplasty or kyphoplasty.Eur Spine J. 2012 May;21(5):905-11. doi: 10.1007/s00586-011-2099-5. Epub 2011 Dec 9. Eur Spine J. 2012. PMID: 22160212 Free PMC article.
-
Risk factors of residual back pain after vertebral augmentation in osteoporotic vertebral compression fracture patients: a systematic review and meta-analysis.BMC Musculoskelet Disord. 2025 Jul 25;26(1):702. doi: 10.1186/s12891-025-08945-w. BMC Musculoskelet Disord. 2025. PMID: 40713499 Free PMC article.
-
Complications in musculoskeletal intervention: important considerations.Semin Intervent Radiol. 2015 Jun;32(2):163-73. doi: 10.1055/s-0035-1549447. Semin Intervent Radiol. 2015. PMID: 26038623 Free PMC article. Review.
-
Osteoporotic vertebral compression fractures and vertebral augmentation.Semin Intervent Radiol. 2008 Dec;25(4):413-24. doi: 10.1055/s-0028-1103000. Semin Intervent Radiol. 2008. PMID: 21326583 Free PMC article.
References
-
- Cook DJ, Guyatt GH, Adachi JD, Clifton J, Griffith LE, Epstein RS, et al. Quality of life issues in women with vertebral fractures due to osteoporosis. Arthritis Rheum. 1993;36:750–756. - PubMed
-
- Kado DM, Browner WS, Palermo L, Nevitt MC, Genant HK, Cummings SR. Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group. Arch Intern Med. 1999;159:1215–1220. - PubMed
-
- Takata S, Yasui N. Disuse osteoporosis. J Med Invest. 2001;48:147–156. - PubMed
-
- Feltes C, Fountas KN, Machinis T, Nikolakakos LG, Dimopoulos V, Davydov R, et al. Immediate and early postoperative pain relief after kyphoplasty without significant restoration of vertebral body height in acute osteoporotic vertebral fractures. Neurosurg Focus. 2005;18:e5. - PubMed
-
- Gold DT. The clinical impact of vertebral fractures: quality of life in women with osteoporosis. Bone. 1996;18(3 Suppl):185S–189S. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical